STOCK TITAN

Elutia Inc. - AZYO STOCK NEWS

Welcome to our dedicated news page for Elutia (Ticker: AZYO), a resource for investors and traders seeking the latest updates and insights on Elutia.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Elutia's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Elutia's position in the market.

Rhea-AI Summary
Elutia Inc. to present at H.C. Wainwright 25th Annual Global Investment Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.27%
Tags
conferences
-
Rhea-AI Summary
Aziyo Biologics changes name to Elutia Inc. and will trade under new ticker symbol 'ELUT'. They will focus on developing drug-eluting biomatrix technology for surgical outcomes. First product launch expected next year in a $600 million market. Expansion into neurostimulator markets anticipated. Second product in development for a $500 million market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.46%
Tags
none
-
Rhea-AI Summary
Aziyo Biologics announces positive results of case study on CanGaroo biological device envelope for reoperative procedures for CIEDs.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.29%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.72%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.75%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.8%
Tags
none
Rhea-AI Summary
Aziyo Biologics announces positive data from the HEAL Study, supporting wound-healing benefits in patients receiving cardiac implantable electronic devices. The study shows that the CanGaroo Envelope, made of an acellular biologic matrix, promotes natural healing and improves patient care during device implantation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.69%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.87%
Tags
none
Elutia Inc.

Nasdaq:AZYO

AZYO Rankings

AZYO Stock Data

24.21M
4.12M
2.18%
70.44%
0.42%
Medical Devices
Healthcare
Link
United States
Silver Spring